Free Trial

Quantinno Capital Management LP Purchases 74,835 Shares of Koninklijke Philips (NYSE:PHG)

Koninklijke Philips logo with Medical background

Quantinno Capital Management LP grew its stake in Koninklijke Philips (NYSE:PHG - Free Report) by 71.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 180,149 shares of the technology company's stock after acquiring an additional 74,835 shares during the period. Quantinno Capital Management LP's holdings in Koninklijke Philips were worth $4,561,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of PHG. Colonial Trust Co SC boosted its position in Koninklijke Philips by 724.0% during the fourth quarter. Colonial Trust Co SC now owns 1,409 shares of the technology company's stock valued at $36,000 after purchasing an additional 1,238 shares during the last quarter. Farther Finance Advisors LLC raised its stake in shares of Koninklijke Philips by 37.1% during the 4th quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company's stock worth $54,000 after purchasing an additional 582 shares in the last quarter. Whipplewood Advisors LLC acquired a new stake in shares of Koninklijke Philips in the 4th quarter valued at approximately $55,000. Millstone Evans Group LLC bought a new position in shares of Koninklijke Philips in the fourth quarter valued at $60,000. Finally, Allworth Financial LP grew its stake in shares of Koninklijke Philips by 24.9% in the fourth quarter. Allworth Financial LP now owns 3,993 shares of the technology company's stock valued at $105,000 after buying an additional 797 shares in the last quarter. Institutional investors and hedge funds own 13.67% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on PHG. BNP Paribas raised shares of Koninklijke Philips from a "neutral" rating to an "outperform" rating in a research report on Tuesday, February 25th. StockNews.com downgraded shares of Koninklijke Philips from a "buy" rating to a "hold" rating in a research note on Monday. UBS Group upgraded Koninklijke Philips from a "neutral" rating to a "buy" rating in a report on Thursday, February 20th. Finally, Sanford C. Bernstein upgraded Koninklijke Philips from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, March 18th. Two equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, Koninklijke Philips has an average rating of "Moderate Buy".

Check Out Our Latest Report on PHG

Koninklijke Philips Stock Performance

Shares of NYSE:PHG traded down $0.54 on Wednesday, hitting $23.42. The company had a trading volume of 1,648,263 shares, compared to its average volume of 819,917. The stock has a market cap of $22.01 billion, a price-to-earnings ratio of -27.88, a P/E/G ratio of 0.82 and a beta of 0.81. The stock has a 50 day moving average price of $24.48 and a 200 day moving average price of $25.71. Koninklijke Philips has a 1-year low of $21.48 and a 1-year high of $32.91. The company has a current ratio of 1.23, a quick ratio of 0.74 and a debt-to-equity ratio of 0.59.

Koninklijke Philips (NYSE:PHG - Get Free Report) last announced its earnings results on Tuesday, May 6th. The technology company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.14 by $0.13. Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. The business had revenue of $4.31 billion during the quarter, compared to the consensus estimate of $4.10 billion. During the same quarter in the previous year, the firm posted $0.21 EPS. Koninklijke Philips's revenue was down 1.0% compared to the same quarter last year. Analysts expect that Koninklijke Philips will post 1.63 EPS for the current year.

Koninklijke Philips Cuts Dividend

The company also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Stockholders of record on Tuesday, May 13th will be issued a dividend of $0.886 per share. This represents a dividend yield of 2.9%. The ex-dividend date of this dividend is Tuesday, May 13th. Koninklijke Philips's dividend payout ratio is presently 174.42%.

Koninklijke Philips Company Profile

(Free Report)

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.

Further Reading

Institutional Ownership by Quarter for Koninklijke Philips (NYSE:PHG)

Should You Invest $1,000 in Koninklijke Philips Right Now?

Before you consider Koninklijke Philips, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.

While Koninklijke Philips currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines